The prevention of cervical cancer in HIV-infected women

AIDS

Volumn 24, Issue 16, 2010, Pages 2579-2580

  Franceschi, Silvia ^a   Ronco, Guglielmo ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b Centre for Cancer Prevention   (Italy)

Author keywords

Cervical cancer; HIV; Human papillomavirus; Screening

Indexed keywords

CANCER PREVENTION; CANCER SCREENING; CRYOTHERAPY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; NOTE; PREVALENCE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; TREATMENT DURATION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; VIRUS TRANSCRIPTION; WART VIRUS;

ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SOUTH AFRICA; UTERINE CERVICAL NEOPLASMS;

EID: 78549292744     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833f39b2     Document Type: Note

References (20)

1. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005;97:577-586. (Pubitemid 40723785)
2. Clifford GM, Goņalves MA, Franceschi S, for the HPV and HIV Study Group. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006;20:2337-2344.
3. IARC. Monographs on the evaluation of carcinogenic risks to humans. Volume 64. Human papillomaviruses. Lyon: International Agency for Research on Cancer;1995, p. 214.
4. Theiler RN, FarrSL, KaronJM, Paramsothy P, Viscidi R, Duerr A, et al. High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol 2010;115:1150-1158.
5. Franceschi S, Jaffe H. Cervical cancer screening of women living with HIV: a must in the post-ART era. Clin Infect Dis 2007;45:510-513.
6. Massad LS, Seaberg EC, Watts DH, Minkoff H, Levine AM, Henry D, et al. Long-term incidence of cervical cancer in women with human immunodeficiency virus. Cancer 2009; 115:524-530.
7. D'Souza G, Jing Y, Strickler H, Silverberg M, Bosch R, Brooks J, et al. Cervical cancer epidemiology among HIV-infected women in North America [abstract number 236]. 26th International Papillomavirus Conference & Clinical and Public Health Workshops; Montreal, Canada, 3-8 July 2010.
8. IARC. IARC handbooks of cancer prevention. Volume 10. Cervix cancer screening. Lyon: IARC Press; 2005.
9. Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007;357:1589-1597.
10. Bulkmans N, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke A, Bulk S, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007;370:1764-1772.
11. Kitchener HC, Almonte M, Thomson C, Wheeler P, Sargent A, Stoykova B, et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 2009;10:672-682.
12. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009;360:1385-1394.
13. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Palma PD, Del Mistro A, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intrae- pithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010;11:249-257.
14. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009;58 (RR-4):1-207.
15. Kitchener H, Nelson L, Adams J, Mesher D, Sasieni P, Cubie H,et al. Colposcopy is not necessary to assess the risk to the cervix in HIV- positive women: an international cohort study of cervical patho- ogy in HIV-1 positivewomen. Int J Cancer 2007; 121:2484-2491.
16. Heard I. Prevention of cervical cancer in women with HIV. Curr Opin HIV AIDS 2009; 4:68-73.
17. Kuhn L, Wang C, Tsai WY, Wright TC, Denny L. Efficacy of HPV- based screen-and-treat for cervical cancer prevention among HIV-infected South African women. AIDS 2010; 24:2553-2561.
18. Taylor S, Wang C, Wright TC, Denny L, Tsai WY, Kuhn L. Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa. BMC Med 2010; 8:40.
19. Harris TG, Burk RD, Palefsky JM, Massad LS, BangJY, Anastos K, et al. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA 2005;293:1471-1476.
20. Cuschieri K, Wentzensen N. Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2008; 17:2536-2545.